Patient Guide: Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 11 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05999604
Status: 🟢 Enrolling Now
Condition: Multiple Sclerosis
Phase: Phase III

Find a Study Location Near You

This study is available at 11 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Créteil,
  • • Gonesse,
  • • Grenoble,
  • • And 8 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily